Wenzler E - Search Results

1

Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists.

Wenzler E, Maximos M, Asempa TE, Biehle L, Schuetz AN, Hirsch EB. Wenzler E, et al. Pharmacotherapy. 2023 Apr;43(4):264-278. doi: 10.1002/phar.2781. Epub 2023 Mar 16. Pharmacotherapy. 2023. PMID: 36825480

2

Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.

Bunnell KL, Wenzler E, Harrington AT, Danziger LH. Bunnell KL, et al. Among authors: wenzler e. Diagn Microbiol Infect Dis. 2018 Apr;90(4):335-336. doi: 10.1016/j.diagmicrobio.2017.12.007. Epub 2017 Dec 16. Diagn Microbiol Infect Dis. 2018. PMID: 29395714

3

Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple Hospitals.

Rock C, Abosi O, Bleasdale S, Colligan E, Diekema DJ, Dullabh P, Gurses AP, Heaney-Huls K, Jacob JT, Kandiah S, Lama S, Leekha S, Mayer J, Mena Lora AJ, Morgan DJ, Osei P, Pau S, Salinas JL, Spivak E, Wenzler E, Cosgrove SE. Rock C, et al. Among authors: wenzler e. Clin Infect Dis. 2022 Sep 30;75(7):1187-1193. doi: 10.1093/cid/ciac074. Clin Infect Dis. 2022. PMID: 35100620

4

Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.

Borjan J, Meyer KA, Shields RK, Wenzler E. Borjan J, et al. Among authors: wenzler e. Int J Antimicrob Agents. 2020 Jan;55(1):105852. doi: 10.1016/j.ijantimicag.2019.11.009. Epub 2019 Nov 23. Int J Antimicrob Agents. 2020. PMID: 31770627

5

Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.

Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; Antibacterial Resistance Leadership Group. Wenzler E, et al. Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00464-18. doi: 10.1128/AAC.00464-18. Print 2018 Aug. Antimicrob Agents Chemother. 2018. PMID: 29891606 Free PMC article. Clinical Trial.

6

Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory Disease.

Wenzler E, Engineer MH, Yaqoob M, Benken ST. Wenzler E, et al. TH Open. 2020 Nov 23;4(4):e376-e382. doi: 10.1055/s-0040-1720962. eCollection 2020 Oct. TH Open. 2020. PMID: 33244512 Free PMC article.

7

Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales.

Biagi M, Lee M, Wu T, Shajee A, Patel S, Deshpande LM, Mendes RE, Wenzler E. Biagi M, et al. Among authors: wenzler e. Diagn Microbiol Infect Dis. 2022 Jun;103(2):115674. doi: 10.1016/j.diagmicrobio.2022.115674. Epub 2022 Mar 10. Diagn Microbiol Infect Dis. 2022. PMID: 35398608

8

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide.

Michienzi SM, Johnson M, Chiampas TD, Wenzler E, Burgos RM, Smith RO, Badowski ME. Michienzi SM, et al. Among authors: wenzler e. Drugs Context. 2021 Jul 23;10:2021-2-1. doi: 10.7573/dic.2021-2-1. eCollection 2021. Drugs Context. 2021. PMID: 34349820 Free PMC article.

9

Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.

Bauer KA, Johnston JEW, Wenzler E, Goff DA, Cook CH, Balada-Llasat JM, Pancholi P, Mangino JE. Bauer KA, et al. Among authors: wenzler e. Anaerobe. 2017 Dec;48:1-6. doi: 10.1016/j.anaerobe.2017.06.009. Epub 2017 Jun 21. Anaerobe. 2017. PMID: 28645479

10

Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.

Meyer K, Santarossa M, Danziger LH, Wenzler E. Meyer K, et al. Among authors: wenzler e. Hosp Pharm. 2017 Mar;52(3):221-228. doi: 10.1310/hpj5203-221. Hosp Pharm. 2017. PMID: 28439137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page